HOME >> MEDICINE >> NEWS
HIV drug resistance increasing in UK and among highest in the world

Those infected with HIV in the UK have one of the highest rates of resistance to anti-HIV drugs of anywhere in the world, prompting fears of a second wave epidemic of resistant virus, a new study claims in this week's BMJ.

The study authors are concerned that the large reductions in deaths and improvements to health since people with HIV were given combinations of drugs (combination antiretroviral therapy) may be compromised because of this.

Using national data on HIV positive cases, the researchers tested patients for resistance to the antiretroviral drugs before embarking on the treatment. Tests were conducted on 2,357 patients between 1996 and 2003 thus researchers could track if there were changes to resistance patterns as time went on.

They found that 335 people showed some degree of resistance to one or more antiretroviral drugs in total. Most of these people 257 were resistant to drugs within one class only, 44 cases showed resistance to drugs within two classes and 34 showed resistance to drugs within all three commonly used drug classes.

Overall, this equates to a 14% rate of resistance to one or more of these drugs among the group studied over the whole time period. The resistance had reached an estimated 19% for the most recent time period of 2002-2003.

The UK's 14% rate of resistance was considerably higher than the 7% estimate for chronically infected patients in the USA, 6% in France and 10% elsewhere in Europe. Direct comparisons should be treated cautiously, however, as different studies have used different definitions of resistance. Using a more conservative definition of resistance (high level resistance to at least one drug) gives an overall estimate of 9% for the UK for the years 1996-2003, with the rate being 12% in 2002-3.

The authors say: 'The United Kingdom has among the highest reported rates of primary resistance to HIV drugs worldwide. By limiting the therapeutic options for a significan
'"/>

Contact: Tersea Hagan
thagan@bma.org.uk
020-738-36174
BMJ-British Medical Journal
17-Nov-2005


Page: 1 2

Related medicine news :

1. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi
2. LAP-BAND System surgery improves insulin resistance
3. New mechanism identified for resistance to targeted lung cancer drugs
4. New project to analyze why Polycystic Ovary Syndrome and insulin resistance are so closely linked
5. Study finds antibiotic resistance in poultry even when antibiotics were not used
6. Drug resistance in an influenza pandemic
7. Rapid flu tests may reduce threat of antibiotic resistance
8. Cancer immunoresistance linked to loss of tumor suppressor gene
9. Key to lung cancer chemo resistance revealed
10. Controlling antibiotics and antibiotic resistance in hospitals
11. Studies identify food sources of disease and drug resistance

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, ... highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, ... this elite group of providers. , Produced by Zeltiq, CoolSculpting is approved by ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... will lecture to primary eye care practitioners on the latest breakthroughs in the ... 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, ...
(Date:1/17/2017)... ... January 17, 2017 , ... Neil H. Greco Insurance Agency, a northern New ... the region, is launching a charity drive to raise awareness of heart disease and ... killer in America, and is responsible for 1 in every 4 deaths at the ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley ... double blind clinical study for its dental gel that shows significant reduction in plaque ... toothpaste containing triclosan. The study was conducted at the Beckman Laser Institute at UC ...
(Date:1/17/2017)... Tyler, TX (PRWEB) , ... January 17, 2017 ... ... serving Texas families from two offices in Tyler, has announced the latest beneficiary ... Red Ribbon Wish Network, a nonprofit organization dedicated to fulfilling the dreams of ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Inc ., a clinical-stage, cancer-selective gene therapy company, today announced ... development at Tocagen, will present at Phacilitate Cell & Gene ... Miami . Details of the podium ... ... what to do when and why Date and Time: Wednesday, Jan. ...
(Date:1/17/2017)... Research and Markets has announced the addition ... Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, ... report to their offering. ... The global active pharmaceutical ingredients market is expected ... in 2016, growing at a CAGR of 6.3% from 2016 to ...
(Date:1/17/2017)... -- Immune Pharmaceuticals (NASDAQ: IMNP ) ("Immune"), ... will hold a Satellite Symposium on February 20th, 2017 at ... Munich, Germany . The ... for the maintenance of remission in AML with Ceplene" ... 2017 from 12:45 – 13:45 CET in Lecture Hall ...
Breaking Medicine Technology:
Cached News: